Institutional Ownership Y M Abs Therapeutics, Inc. (YMAB)
This table provides information about the institutional ownership of Y M Abs Therapeutics, Inc. (YMAB). We have compiled data on the 106 institutions that hold shares in the stock, with a total of 24.5 Million shares, which have been reported (via 13F filing form) to have a value of $152 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
4,086,346
shares
|
$24.4 Million
1.93% of portfolio
|
Q3 2024
Added 5.57%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,938,718
shares
|
$17.5 Million
0.0% of portfolio
|
Q2 2024
Added 2.85%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2024 Q3 2024 |
2,194,278
shares
|
$13.1 Million
2.73% of portfolio
|
Q4 2019
Added 4.28%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,035,363
shares
|
$12.2 Million
0.0% of portfolio
|
Q3 2024
Added 3.99%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
1,831,000
shares
|
$10.9 Million
0.15% of portfolio
|
Q1 2024
Reduced 10.98%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,450,000
shares
|
$8.66 Million
1.33% of portfolio
|
Q2 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,209,781
shares
|
$7.22 Million
0.0% of portfolio
|
Q3 2024
Added 50.36%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
813,489
shares
|
$4.86 Million
0.0% of portfolio
|
Q3 2024
Added 6.25%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
800,000
shares
|
$4.78 Million
1.39% of portfolio
|
Q3 2024
New holding
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
787,536
shares
|
$4.7 Million
0.01% of portfolio
|
Q3 2024
Reduced 14.99%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
687,980
shares
|
$4.11 Million
0.01% of portfolio
|
Q3 2024
Added 4.29%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
557,429
shares
|
$3.33 Million
0.2% of portfolio
|
Q3 2024
Added 50.92%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
477,664
shares
|
$2.85 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.4%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
399,982
shares
|
$2.39 Million
0.45% of portfolio
|
Q3 2024
Reduced 38.27%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
337,287
shares
|
$2.01 Million
0.0% of portfolio
|
Q3 2024
Added 6.13%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
279,577
shares
|
$1.67 Million
0.0% of portfolio
|
Q3 2024
Added 9.38%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
274,547
shares
|
$1.64 Million
0.0% of portfolio
|
Q3 2024
Added 4.89%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
248,722
shares
|
$1.48 Million
0.0% of portfolio
|
Q3 2024
Added 22.44%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
222,600
shares
|
$1.33 Million
0.0% of portfolio
|
Q3 2024
Added 60.45%
|
|
|
Memorial Sloan Kettering Cancer Center
New York, NY |
Nov 14, 2023 Q3 2023 |
191,176
shares
|
$1.14 Million
4.24% of portfolio
|
Q4 2021
Reduced 11.87%
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
154,931
shares
|
$924,938
0.0% of portfolio
|
Q3 2024
Added 22.58%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
149,681
shares
|
$893,595
0.01% of portfolio
|
Q2 2024
Reduced 2.81%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
136,714
shares
|
$816,182
0.0% of portfolio
|
Q3 2024
Reduced 14.79%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
112,483
shares
|
$671,523
0.0% of portfolio
|
Q2 2024
Reduced 57.99%
|
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
108,549
shares
|
$648,037
0.05% of portfolio
|
Q4 2024
Reduced 0.12%
|